Recce Pharmaceuticals Ltd.ASX: RCE

Patient Dosing Underway in Ph 3 Indonesia DFI Trial

Sep 25, 2025 at 4:10 AM UTC · Issued by Recce Pharmaceuticals Ltd.

Recce Ltd has released a press release.

View Attachment